Scilex Holding (SCLX) Amortizatization of Intangibles (2022)
Scilex Holding (SCLX) recorded quarterly Amortizatization of Intangibles of $1155.0 in Q3 2022, down 86.05% quarter-over-quarter from $8280.0 in Q2 2022.
Scilex Holding (SCLX) Amortizatization of Intangibles (2022) Analysis & Trends
Scilex Holding's Amortizatization of Intangibles history runs 1 years deep, the most recent figure standing at $1155.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,162,528.78 Bn | 93,162,523.82 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,017.87 Bn | 1,012.58 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 575.51 Bn | 553.46 Bn | 15.96 Bn | - |
| 4 | AbbVie | 400.43 Bn | 391.08 Bn | 10.78 Bn | 1.70 Bn |
| 5 | Merck | 294.19 Bn | 288.54 Bn | 12.09 Bn | 931.00 Mn |
| 6 | Amgen | 182.41 Bn | 170.37 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 150.97 Bn | 143.24 Bn | 5.52 Bn | 596.00 Mn |
| 8 | Pfizer | 145.75 Bn | 132.97 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 113.35 Bn | 102.90 Bn | 8.07 Bn | - |
| 10 | Scilex Holding | 57.99 Mn | -91.94 Mn | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,155.00 |
| Sep 30, 2022 | 1,155.00 |
| Jun 30, 2022 | 8,280.00 |
| Jun 30, 2022 | 8,280.00 |
| Mar 31, 2022 | 7,466.00 |
| Mar 31, 2022 | 7,466.00 |